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ABSTRACT The structural integrityof erythrocyte ghosts made
by the preswell and slow-dialysis techniques has been studied in
vitro by use of y-ray perturbed angular correlation (PAC) tech-
niques and also by standard in vitro leakage methods employing
sequestered labeled markers. Complexes of "'In3+ and nitrilo-
triacetate were encapsulated in ghosts made from human, rabbit,
rat, and mouse erythrocytes, and their leakage was monitored by
both methods. In addition, "2'I-labeled bovine serum albumin was
encapsulated, and ghost integrity was monitored by conventional
leakage measurements. With the PAC technique the percentage
of material released from human ghosts was determined quanti-
tatively, and the results were equivalent to those obtained by the
conventional method. In addition, at various times after intrave-
nous injection, tissue distribution of the ghosts in the mouse was
studied. The percent injected dose per gram of tissue of the la-
beled surface proteins of erythrocyte ghosts in circulation ap-
proximated that of the entrapped labeled albumin. This suggests
that the ghost membrane and contents are strongly associated in
viva Large "MI-labeled bovine serum albumin molecules and small
"'1In3+-nitrilotriacetate complexes were delivered in high quan-
tities to the lung initially, and to the liver and spleen. Because
erythrocyte ghosts have the ability to entrap a wide range of sub-
stances and deliver them to specific organs, ghosts may be pref-
erable to other drug carriers or drug therapy for treatment of cer-
tain disorders.
An attractive strategy for the in vivo delivery of biologically ac-
tive molecules is the encapsulation of drugs or enzymes in
erythrocytes. As carriers, erythrocytes offer several advantages
over other systems: they can entrap large volumes of concen-
trated loading material, and they can avoid host immunologic
reactions if they are from isologous or autologous blood. Dif-
ferent enzymes and drugs have been successfully encapsulated
by erythrocytes and delivered to specific cell and tissue sites in
animal models (1-3). Methods of entrapment, such as the pre-
swell, rapid-lysis, and slow-dialysis methods, involve variations
of erythrocyte osmotic lysing and resealing (4, 5); methods such
as applying an external pulsed electric field or drug treatment
induce membrane permeability changes or endocytic activity in
erythrocytes (1, 4, 6). The successful entrapment of various ac-
tive enzymes, transport systems, and drugs has been demon-
strated (1-9). To develop theerythrocyte ghosts as practical car-
rier systems, we have studied the leakage of entrapped substances
from ghosts of different species prepared by various methods,
and we have studied the fate of the erythrocyte ghosts after
administration in vivo.
y-Ray perturbed angular correlation (PAC) techniques have
been used to monitor the changes of lipid vesicles of different
compositions in vitro and in vivo (10, 11). With PAC, Hwang
and Mauk (12) showed that the integrity of liposomes in vivo can
be assessed by monitoring changes of rotational correlation time
of 1"'In3" encapsulated in the carrier: a high tumbling rate is
observed when the encapsulated "1'In3" is chelated to small
molecules; the tumbling rate decreases if "1'In3" is released from
the carrier and binds to proteins in circulation or to serum pro-
teins in vitro. In this paper we describe the application of the
PAC technique to characterize the integrity of annealed eryth-
rocyte ghosts from mouse, rat, rabbit, and human sources made
by the preswell and dialysis techniques. The strategy applied to
monitor the integrity of lipid vesicles is thus extended to eryth-
rocyte ghosts, alternative model membrane carriers for drugs
and enzymes.
MATERIALS AND METHODS
Preparation of Labeled Erythrocyte Ghosts. Intact human
erythrocytes were isolated from freshly drawn heparinized
blood. Whole blood was centrifuged at 1,000 X g for 10 min at
40C. The serum and buffy coat were removed and the packed
cells were washed three times in 10 vol of phosphate-buffered
saline (Pi/NaCl; 5 mM sodium phosphate buffer, pH 7.4/0.15
M NaCl). Freshly drawn blood from rabbits (New Zealand), rats
(Fischer 433), or mice (Swiss-Webster) was obtained from
LabPets (Pasadena, CA) and washed as described for the human
erythrocytes.
Erythrocyte ghosts were made by either the preswell or the
slow-dialysis techniques. The two techniques are variations of
osmotic lysing that differ from each other by the volume of hy-
potonic saline used to hemolyze the cells and the rate at which
the cells swell before lysis. With both techniques, conservation
of the loading substance can be achieved because the ratio of
erythrocytes to lysis buffer is small (5).
Preswell erythrocyte ghosts were loaded with a 10 mg/ml
solution of "2I-labeled bovine serum albumin ("2I-albumin) as
described (5). The preparation of slow-dialysis erythrocyte ghosts
(Fig. 1) loaded with 125I-albumin follows that described by Kruse
et aL (13) with modifications: (i) nitrilotriacetate (NTA; 1 mM)
was present in the buffer solutions during the lysis and resealing
steps so that chelator scavengers could be eliminated from the
system, (ii) the annealing period was extended to 30 min be-
cause the membranes leaked less of the entrapped markers, (iii)
ghosts were pelleted at 12,000 x g for 10 s with an Eppendorf
microcentrifuge. Radioiodination of the albumin was per-
formed with TODO-GEN (Pierce) (14). Typically, 0.5 mCi (1 Ci
= 3.7 x 10"0 Bq) of Na'25I was used for iodination, and after
desalting on Sephadex G-50, the "2I-albumin was added to al-
bumin in Pi/NaCl (10 mg/ml) and this solution was used for
Abbreviations: PAC, perturbed angular correlation; P,/NaCl, phos-
phate-buffered saline; NTA, nitrilotriacetate.
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e BSA (10mg/mi) in PBS
RBCs + BSA in PBS
Dialyze 90min at 41C vs. 5mM No phosphate
buffer, pH 7.4 containing 1mM NTA
Hypotonically Lysed RBCs
Dialyze 30min at 251C vs. PBS containing
I1mM NTA
Resealed RBC Ghosts
l Incubate 30 min at 371C (±R+ in No citrate)
Annealed RBC Ghosts
Centrifuge 10s at 12000 Xg
Wash 3x c PBS, first wash containing 1 mM
EDTA
BSA (±111In3) Loaded RBC Ghosts
FIG. 1. Erythrocyte loading by the slow-dialysis method. RBCs,
erythrocytes; BSA, bovine serum albumin; c, with; PBS, Pi/NaCl.
loading erythrocytes in a ratio of albumin to packed erythro-
cytes of 1:1.5. Erythrocyte surface proteins were labeled in the
same manner, with 0.1 ml of washed, packed erythrocytes; free
iodine was removed by dialysis for 1 hr at 40C. A short dialysis
time was preferable because it closely reflected the time used
for ghost preparation and resulted in minimal crenation of the
intact cells. 111In3+-Loaded erythrocyte ghosts were prepared
by a similar procedure. Unlabeled albumin was used as before
to maintain the protein concentration; during the 370C an-
nealing step 50-100 p.Ci of "'1In3+ in 2 mM HCI plus 30 ttl of
3.4 ttM InCl3 in 0.1 /iM sodium citrate (pH 7.4) and 30 dul of
2x Pi/NaCl were added to 0.5 ml of packed erythrocyte ghosts.
To obtain erythrocyte ghosts with a high specific activity the
label was added at the annealing step. Carrier-free 11'InCl3
(Medi+Physics, Emeryville, CA) was chromatographed on a
Bio-Rad AG 1X-8 column (0.7 X 10 cm) in 0.1 M HCL. The peak
fraction was collected in a 10-ml disposable polystyrene beaker,
dried under a heat lamp, and reconstituted in 0.1 ml of 0.002
M HC1 (=3 mCi/0. 1 ml). Portions of this stock were taken for
erythrocyte loading experiments. The calcium ionophore A23187
did not appreciably increase the uptake of 111In3+ by the ghosts
as it does for vesicles (15) in the concentration 0.04 kumol of
A23187 per ml of packed erythrocytes; thus it was not used in
the experiments reported here. The washing was as described
(13) except the first wash was with 10 mM EDTA in P,/NaCl
to facilitate removal of free radioactive "'In3+ and that which
is nonspecifically bound to the cell surface. The erythrocytes
were suspended in P1/NaCI or in serum (1:1) for PAC mea-
surements.
In Vitro Studies. For in vitro leakage studies a suspension of
erythrocyte ghosts in Pi/NaCl was made and equal portions were
put into 1.5-ml microcentrifuge tubes. After incubation at 370C
for given periods, the tubes were centrifuged in the microcen-
trifuge for 10 s to-pellet the cells. The supernatant and one wash
of the ghost pellet with P1/NaCl were collected along with the
pellet. The samples were placed in 12 x 75 mm tubes and the
y-ray activity was measured.
In Vivo Studies. A suspension of labeled mouse erythrocyte
ghosts (0.2 ml) was administered to Swiss-Webster mice (18-
25 g) by intravenous (tail vein) injection. The amount of '11In3"
or 11-I-albumin administered ranged between 1 and 20 ,uCi per
mouse. As controls, some mice were given 0.2-ml injections of
free label (e.g., "'In3" or '251-albumin) in P1/NaCl. Also, a full
dose (0.2 ml) and an aliquot (0.1 ml) were obtained from the
syringe and analyzed for radioactivity. The tissue distribution
of injected radioactivity was determined by assaying washed
and blotted tissues of the mouse in a y-ray spectrometer. The
tissue distribution of label was measured at various intervals
after intravenous injection of radiolabeled ghosts. We assumed
that blood made up 7.3% of the total body weight of the animal.
Mice receiving an imperfect injection (e.g., >10% of the in-
jected dose per gram of tissue for the tail) were eliminated from
consideration. Typically, 3 or 4 mice were used for each group
of time points.
PAC Spectroscopy. The PAC technique was developed to
monitor the changes in the rotational correlation time of suitable
radioactive nuclei bound to various molecules (16). The tech-
nique requires the use of a radioactive nucleus that decays by
emitting two y-rays in succession. The "'In3" we employ here
undergoes electron capture and subsequently decays, emitting
two y-rays with energies of 173 and 247 keV. A correlation exists
between the directions of propagation of the emitted y-rays,
which are detected by a coincidence spectrometer. The angular
correlation can be perturbed if, in the time between emission
of the first and second gamma rays, the nucleus interacts ap-
preciably with its environment. PAC studies provide informa-
tion concerning changes in the tumbling rate of "'Lnn3' bound
to molecules with different rotational correlation times. Carrier-
entrapped "'LIn3+ chelated to a small molecule has a short ro-
tational correlation time. If the "'In3+ probe is released from
the carrier and binds to a macromolecule, its rotational corre-
lation time increases substantially. Monitoring the average ro-
tational correlation time of the "'Lnn3+ probe thus provides a
measure of the integrity of the carrier in vitro or in vivo.
RESULTS
Slow-dialysis and preswell methods were used for loading the
"1In3+ cation into erythrocyte ghosts. When human and mouse
erythrocyte ghosts were annealed for 30 min or longer, the
membranes leaked less of the entrapped markers (e.g., "'In3+
and "2I-albumin). The preswell ghosts leaked more "'1In3+ than
did the slow-dialysis ghosts, which suggests that the preswell
procedure for making ghosts is more harsh.
Measurements of (G22(o)), a quantity proportional to the ro-
tational correlation time for "'In3+ in various environments,
were obtained by PAC spectroscopy (Table 1). The G22 values
were about the same for the "'In3+-NTA complex in the pres-
ence of albumin, intact human erythrocytes, and annealed
erythrocyte ghosts. Thus, nonspecific binding of the "'Lin3+ to
these components was not significant; the rotational correlation
time of "'In3+-NTA entrapped within the erythrocyte ghosts
was less than that for the free complex, indicating a somewhat
higher viscosity inside the resealed ghosts. The slow-dialysis
human ghosts were fairly stable as determined by PAC. When
incubated with serum at 370C, human ghost leakage deter-
mined from G22 values always was between 10% and 20% after
2 days. The leakage in vitro for ghosts of erythrocytes from other
animal species could not be reliably determined by PAC mea-
surements because of high initial leakage rates of entrapped
markers.
In vitro leakage of entrapped markers from erythrocyte ghosts
made from different species was also monitored by conventional
techniques. The ghosts were suspended in Pi/NaCl and incu-
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Table 1. Value of (G22(oo)) for 111In3' in various~environments
Sample (G22(oo))
I NTA-11'In3+ complex in Pi/NaCl 0.75 ± 0.04
With serum (1:1) 0.30 ± 0.01
With albumin (1 mg/ml; 1:1) 0.78 ± 0.05
With intact human erythrocytes (1:1) 0.70 ± 0.04
With reannealed human ghosts (1:1) 0.77 ± 0.01
II 111In3+-albumin-loaded human ghosts,
slow dialysis 0.61 ± 0.02
With serum 0.56 ± 0.03
With serum and isopropyl alcohol 0.30 ± 0.01.
11In3+-albumin-loaded human ghosts,
preswell 0.64 ± 0.01
With serum 0.57 ± 0.01.
With serum and isopropyl alcohol 0.32 ± 0.02
PAC measurements of "'1In3+ in the presence of componentspresent
in significant quantities during the loading of erythrocytes or en-
trapped within erythrocyte ghosts. The-G22 values for the first group
of results (I) are the mean ± SD calculated from values obtained-from
monitoring the sample for at least 2 hr. The G22 values for the second
group of results (II) are initial values obtained approximately. 15.min
after the final wash step in the sample preparation, except for the sam-
ples with isopropyl alcohol, the values of which were obtained after
monitoring.the sample for at least 2 hr. The isopropyl alcohol is added
to disrupt the integrity of the ghosts.
bated at 37TC for various periods. Fig. 2 shows the percent of
labeled marker (cpm) remaining with the ghosts at given times.
The human ghosts were remarkably stable over a 26-hr period
under the given conditions. The erythrocyte ghosts of other an-
imal species exhibited a much greater leakage of contents,
whether determined by the very small "'1In3+ marker or the
larger albumin marker. Rabbit and rat erythrocyte ghosts ex-
hibited a high initial loss of contents followed by a slow release
of entrapped markers over a 26-hr period. The integrity of the
mouse ghosts was good initially; however, they steadily lost a
major portion of the markers within the first 4 hr of incubation.
Two different labels ("'In"+ and 1"I) were used to study the
tissue'distributions of mouse erythrocytes and ghosts. Both the
"'In3+-NTA complex and "I-albumin were used as- internal
aqueous markers. In addition, 1"I was used to label the surface
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FIG. 2. Integrity of 125I-albumin and."1In3+-loaded'erythrocyte
ghosts, made by the slow.dialysis technique. Human (c), rabbit (A), rat
(c), and mouse (o) ghost leakage was determined from the y-ray ac-
tivity of supernatant, wash, and ghost pellet at given times.
Table 2 contains data showing the disposition in vivo of labeled
marker after intravenous injection of "'In3"-loaded mouse
ghosts, '"I-albumin-loaded mouse ghosts, "2I-labeled mouse
ghosts, and "MI-labeled mouse erythrocytes into mice after given
times. "'In3+-Loaded mouse ghosts rapidly cleared from cir-
culation; a high percentage of the injected ghosts (per gram of
tissue) initially was found in the lung. The liver and spleen, in
30 min, showed maximal accumulation of activity.
The '"I-albumin-loaded-mouse erythrocyte data closely par-
alleled the '2I-labeled erythrocyte ghost protein data (e.g., la-
bel ofcarrier versus the carried). This paralIelism, however, was
not obtained for the "MI-labeled ghosts and the "MI-labeled
erythrocytes. Similar to "'1In3"-loaded ghosts, high values (per-
cent injected dose per gram oftissue) for the "251-labeled ghosts
were found in the spleen and liver. Conversely, intact eryth-
rocytes were maintained in circulation longer and not filtered
by the spleen as dramatically as the ghosts. The free labels
("'In3+-NTA complex and l 5I-albumin in Pi/NaC1) injected
into mice appeared in the blood and kidney at higher levels than
when entrapped in ghosts. These findings suggest that a size-
able quantity of loaded material was released from the mouse
ghosts shortly after they were annealed. This initial loss of
loaded material gave rise to the unexpectedly high activity
found in the kidney and blood with respect to "'1In3+- and 125I-
albumin-loaded ghosts. These data are consistent with our in
vitro findings, which also indicated a high initial loss of activity
from the ghosts.
DISCUSSION
Previous PAC investigations have been performed on fairly ho-
mogeneous liposome preparations. The erythrocyte ghost prep-
arations analyzed by PAC in this report are complex mixtures
(17), containing components of varying stability. A heteroge-
neous population of ghosts may result from the loading pro-
cedures, and, in fact, there is evidence that irreversible alter-
ations of the membrane occur, mainly due to the temporary
exposure of the membrane to low ionic strength. In this study,
the ratio'of white ghosts to red ghosts increased with time. Thus,
the white ghosts could represent the most stable population of
loaded ghosts formed. We found that PAC measurements for
human ghosts were reproducible; a sufficient differential in the
G22 values allowed us to analyze reliably the leakage of en-
trapped markers. The greater stability of the human ghosts
would make them useful for in vivo studies by PAC. However,
the starting populations of ghosts made from rabbit, rat, and
mouse erythrocytes had leakage rates so great that resulting G22
values were too low to allow reliable analysis by PAC. The in
vitro leakage studies by the conventional method are consistent
with this observation.
Fiddler et al. (4) entrapped &3-glucuronidase, glucose, and
inulin in human erythrocytes. After a 3-hr 370C incubation in
buffered whole blood, less than 1% leakage of the.enzyme and
less than 11% leakage of glucose or inulin occurred. Our find-
ings with the albumin marker are in general agreement with
their results. It was demonstrated recently that human eryth-
rocyte ghosts with entrapped Ca2+ chelated to EGTA and dex-
tran (Mr 80,000) did not leak Ca2+ after washing and subsequent
incubation for up to 90 min at 37C (18). This observation is
consistent with the results reported here for human erythrocyte
ghosts with entrapped In3+ chelated to NTA. Thus, human
erythrocyte ghosts can act as stable containers ofeven very small
components, especially when transport systems for those com-
ponents are not present in the carrier membrane.
Erythrocytes from various animal species are basically of sim-
ilar composition, yet significant differences exist for each kind
that presumably improve their survival in their host. The mouse
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Table 2. Disposition of "1'In3+ and '251-albumin in mouse tissues after intravenous injection of erythrocyte ghost-entrapped labels and free
labels at given times
Time, % injected dose per gram of tissue
Sample min Blood Lung Liver Spleen Kidney
"1In3+-Albumin- 15 5.8 ± 1.9 (28.5) 29.4 ± 8.7 (13.2) 26.9 ± 10.6 (6.6) 36.3 ± 19.6 (6.6) 14.7 ± 6.2 (26.3)
loaded ghosts 30 7.1 29.5 29.6 62.9 23.4
60 4.8 ± 1.5 (11.4) 11.6 ± 2.0 (10.8) 30.7 ± 3.6 (5.6) 45.2 ± 9.1 (5.3) 19.7 ± 4.0 (24.5)
180 2.9 7.06 25.43 46.28 23.15
5I-Albumin- 15 38.8 ± 2.8 (32.8) 15.5 ± 7.3 (13.1) 19.1 ± 2.8 (6.4) 115.9 ± 27.8 (4.7) 4.0 ± 1.2 (8.1)
loaded ghosts 30 23.1 ± 1.3 8.1 ± 1.0 23.2 ± 3.5 238.0 ± 55.4 5.4 ± 1.1
60 9.5 ± 5.4 (22.4) 5.7 ± 1.4 (10.4) 22.2 ± 2.4 (4.9) 158.9 ± 31.7 (3.1) 4.0 ± 1.6 (6.7)
180 3.4 1.7 6.2 79.0 2.3
'25I-Labeled 15 28.9 19.0 26.2 114.5 5.2
ghosts 60 14.8 9.9 28.6 102.6 4.4
125I-Labeled 15 27.9 49.8 17.2 7.8 57.1*
erythrocytes 60 28.8 34.1 14.1 6.2 9.4
Values are the mean (±SD, where given). Values in parentheses are for the respective free labels, "1In3+-NTA complex or 125I-albumin, in Pi/NaCl.
For blood, the values were normalized to 7.3% of the total body weight.
* The high value for the kidney at this time probably reflects the presence of excess free label in the injected sample, which was dialyzed for 1 hr
at 40C.
erythrocyte has an average diameter of 5.9 ,um (mean cell vol-
ume, 41-52 t.m3). The lifespan of mouse erythrocytes is be-
tween 20 and 30 days. The average diameter of erythrocytes
from rat and rabbit is slightly larger (6.5-7.5 /im; mean cell vol-
ume, 60-68 ,Um3) and the lifespan of these erythrocytes is be-
tween 60 and 70 days. The body temperatures of these animals
are higher than the temperature in humans and their blood cell
composition reflects a high reticulocyte count. Reticulocytes
(immature erythrocytes) commonly make up 3-4% of eryth-
rocytes in the blood of the mouse, rat, and rabbit, although val-
ues as high as 10% have been reported (19). In contrast, the hu-
man erythrocyte average diameter is 7-8.6 ,um (mean cell volume,
100 ,m3); the life span is 120-127 days; the reticulocyte count
is 0.1-1.5%. Erythrocytes from different animals show different
stability in hypotonic solution. In general, increasing stability
correlates with increasing mean erythrocyte volume (18). The
results of the studies reported here show that the larger human
ghosts are significantly more stable than the smaller ghosts from
the other species tested. In addition, our results suggest that
current methods used to load human erythrocytes are not ad-
equate for loading erythrocytes from other animal species.
Our study shows a significant clearing of ghosts by the re-
ticuloendothelial system in comparison to washed, intact eryth-
rocytes. Fiddler et al. (4) observed morphologic changes of
erythrocyte ghosts, made by several methods, to echinocytes or
stomatocytes. In fact, simply washing erythrocytes can cause
the cell shape to change to an echinocytic form, possibly because
various plasma proteins are removed from the surface of the
erythrocyte (20). These morphologic forms presumably are cleared
by the reticuloendothelial system more rapidly than normal dis-
coid erythrocytes. Ghosts made by the dialysis technique have
been shown to retain their discoid shape to a greater extent (4).
Thus, this method of preparing ghosts may prolong their life-
time in vivo. Beutler et aL (21) have demonstrated, in an asplenic
patient, a half-life range of 14 hr to 10 days for 51Cr-labeled ghosts
with entrapped enzyme made by a dialysis procedure. With the
advent of techniques to separate stable, highly loaded popu-
lations of ghosts from irreversibly lysed, unloaded, and unstable
ghosts (17), delivery systems with the erythrocyte ghost as a
biodegradable carrier may be developed to their full potential.
We have shown that PAC spectroscopy can be used to mon-
itor the stability of human erythrocyte ghosts in vitro. In ad-
dition, these studies demonstrate that erythrocyte ghosts can
entrap agents and offer a means to deliver these agents to re-
ticuloendothelial cells. Organs with erythrophagocytic activity,
including spleen, liver, and bone marrow, are natural targets for
erythrocyte ghosts. We believe, as Ihler suggested (8), that drug-
loaded erythrocytes could be used for treatment of cancers of
these tissues, namely monocytic leukemia, reticulum cell sar-
coma, and histiocytic medullary reticulosis. Possibly, surface-
modified ghosts could be used for treatment of hepatic or other
cancers.
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